SEC Form 4 · accession 0001193125-26-259699
BioAtla, Inc. · BCAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Vasquez
Officer — Chief Financial Officer
Period of report
Mar 11, 2026
Accepted (ET)
Jun 5, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001826892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 11, 2026 | F | 175 | $0.169 | D | 10,429 | D | |
| Common StockF2 | May 31, 2026 | F | 82 | $3.93 | D | 10,347 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
- F2Effective on April 6, 2026, the Issuer effected a 50-for-1 share consolidation of its common stock (the "Share Consolidation"). The amount of securities reported on this Form 4 has been adjusted to reflect the Share Consolidation.